Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Grade Glioma: Glioblastoma (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02664363
What this trial is testing

EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma

Who this might be right for
GlioblastomaGliosarcoma
Daniel Landi 3
Early research (Phase 1)Looking for participantsNCT07551336
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Who this might be right for
Malignant GliomaHigh-Grade GliomasGlioblastoma+2 more
Beijing Biotech 36
Not applicableLooking for participantsNCT05954858
What this trial is testing

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

Who this might be right for
Glioma, MalignantGlioblastomaGlioblastoma Multiforme+4 more
Northwell Health 32
Not applicableNot Yet RecruitingNCT07532031
What this trial is testing

APT-weighted and Diffusion MRI for Characterizing Tumor Infiltration in High-Grade Gliomas

Who this might be right for
High-Grade GliomaGlioblastomaBrain Tumor Adult
IRCCS Ospedale San Raffaele 20
Testing effectiveness (Phase 2)Ended earlyNCT03018288
What this trial is testing

Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)

Who this might be right for
Glioblastoma
National Cancer Institute (NCI) 90
Early research (Phase 1)Study completedNCT00003876
What this trial is testing

Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01303835
What this trial is testing

Low Dose Naltrexone for Glioma Patients

Who this might be right for
Malignant Glioma
Katy Peters 110
Testing effectiveness (Phase 2)Ended earlyNCT01189240
What this trial is testing

RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)Study completedNCT01738646
What this trial is testing

Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients

Who this might be right for
Recurrent Glioblastoma MultiformeMalignant GliomaAdult Brain Tumor
Duke University 48
Testing effectiveness (Phase 2)Study completedNCT04817254
What this trial is testing

Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcomaMalignant Glioma
National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)WithdrawnNCT01445691
What this trial is testing

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery

Who this might be right for
Benign Neoplasms, BrainBrain CancerBrain Neoplasms, Benign+12 more
Constantinos Hadjipanayis
Early research (Phase 1)Study completedNCT00003410
What this trial is testing

Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Not applicableActive Not RecruitingNCT07448480
What this trial is testing

Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas

Who this might be right for
Recurrent Malignant GliomaGlioblastomaAnaplastic Astrocytoma+1 more
Blokhin's Russian Cancer Research Center 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05736406
What this trial is testing

A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma

Who this might be right for
Primary Glioblastoma
Hemerion Therapeutics 12
Testing effectiveness (Phase 2)Ended earlyNCT01868906
What this trial is testing

FMISO-PET in Brain Tumors and SCS Effect

Who this might be right for
Malignant Glioma
Bernardino Clavo, MD, PhD 6
Testing effectiveness (Phase 2)Study completedNCT00079092
What this trial is testing

Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Wake Forest University Health Sciences 18
Testing effectiveness (Phase 2)Study completedNCT01213407
What this trial is testing

Dendritic Cell Cancer Vaccine for High-grade Glioma

Who this might be right for
Glioblastoma Multiforme
Activartis Biotech 87
Testing effectiveness (Phase 2)Ended earlyNCT01966809
What this trial is testing

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 1
Early research (Phase 1)Looking for participantsNCT07480941
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Who this might be right for
GlioblastomaHigh-grade GliomaMalignant Glioma+2 more
Beijing Biotech 36
Not applicableStudy completedNCT02473484
What this trial is testing

Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas

Who this might be right for
Glioblastoma
University Hospital, Lille 78
Next Page